Retinopatia Diabética II (Diabetic Retinopathy II)

■ Diabetic retinopathy classification for supervised machine learning algorithms

Luis Filipe Nakayama, Lucas Zago Ribeiro, Mariana Batista Gonçalves et al

Int J Retina Vitreous. 2022; 8: 1

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722080/

■ Validation of an algorithm for the prediction of diabetic retinopathy in type 1 diabetic patients in a Spanish population

Pedro Romero-Aroca, Marc Baget-Bernaldiz, Raul Navarro-Gil et al

Clin Ophthalmol. 2022; 16: 715–72

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921832/

■ Management of acute proliferative diabetic retinopathy related complications during the first COVID-19 wave

N Dhillon, S Santiago

BMC Ophthalmol 2022, vol 22: 119

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917785/

■ The effect of diet and lifestyle on the course of diabetic rfetinopathy – a review of the literature

Anna Bryl, Małgorzata Mrugacz, Mariusz Falkowski, Katarzyna Zorena

Nutrients. 2022 Mar; 14(6): 1252

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955064/

■ Epidemiology of moderately severe and severe non-proliferative diabetic retinopathy in South West England

C R Nevill, I M Stratton, S S Maruti et al

Eye (Lond) 2022, vol 36 (2): 433-440

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807748/

■ Infographic: intravitreous aflibercept vs vitrectomy with panretinal pjotocoagulation for vitreous haemorrage from proliferative diabeteic retinopathy

A Song, A Ghareeb, A Methta et al

Eye (Lond) 2022, vol 36 (1): 8-9

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727675/

■ Automated feature-based grading and progression analysis of diabetic retinopathy

L Al-Turk, J Wawrzynski, S Wang et al

Eye (Lond) 2022, vol 36 (3): 524-532

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873224/

■ Optical coherence tomography in diabetes: focus on microaneurysms

G Querques, E Borreli, M Battista et al

Eye (Lond) 2021, vol 35 (1): 142-148

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852676/

■ Review of retinal cameras for global coverage of diabetic retinopathy screening

R Rajalakshmi, V Prathiba, S Arulmalar, M Usha

Eye (Lond) 2021, vol 35 (1): 162-172

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852572/

■ How is the risk of being diagnosed with referable diabetic retinopathy affected by failure to attend diabetes wye screening appointments?

R Virk, A M Binns, R Chambers, J Anderson

Eye (Lond) 2021, vol 35 (2): 477-483

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027199/

■ A virtual-clinic pahway for patients referred from a national diabetes eye screening programme reduces servisse dedmands whilst maintaining quality of care

L Faes, D J Fu, J Huemer et al

Eye (Lond) 2021, vol 35 (8): 2260-2269

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596837/

■ Early structural and functional neurovascular changes in the retina in the pediabetic stage

D Ratra, R Nagarajan, D Dalan et al

Eye (Lond) 2021, vol 35 (3): 858-867

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026633/

■ Comparison of automated and expert human grading of diabetic retinopathy using smartphone-based retinal photography

T N Kim, M T Aaberg, P Li et al

Eye (Lond) 2021, vol 35 (1): 334-342

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852658/

■ Retinopatia Diabética: Artigos de Revisão (Diabetic Retinopathy: Reviews)